Ozone Pharmaceuticals eyes Rs 1,000 crore topline in next 3 years

According to the statement, Ozone launched its Molecule initiative with a vision to become the world's foremost pain management company.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/qrlwLxd
via IFTTT